Skip to main content
logo
Sumitomo Pharma Co., Ltd. (TYO:4506)
Japan flag Japan · Delayed Price · Currency is JPY
1,345.00
+50.00 (3.86%)
Aug 10, 2026, 3:30 PM JST

Sumitomo Pharma Cash Flow Statement

Millions JPY. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
112,656106,86523,634-314,929-96,71440,600
Depreciation & Amortization
18,82419,12823,27437,76541,26338,348
Other Amortization
1,6581,6582,288---
Loss (Gain) From Sale of Assets
-49,043-49,043-13,537180,85775,850769
Asset Writedown & Restructuring Costs
2,0732,0735,189---
Loss (Gain) From Sale of Investments
-3,335-3,193-2,568-5,890-24,735-
Other Operating Activities
-8,85011,199-3,010-37,226-25,236-41,871
Change in Accounts Receivable
-46,332-50,774-90923,39051,218-6,097
Change in Inventory
12,7419,00518,837-11,7954,5605,356
Change in Accounts Payable
14,29424,431-25,8685,6455,318-28,669
Change in Unearned Revenue
-13,481-13,153-25,822---
Change in Other Net Operating Assets
23,25913,51914,992-119,710-19,58722,803
Operating Cash Flow
64,46471,71516,500-241,89311,93731,239
Operating Cash Flow Growth
55.86%334.64%---61.79%-76.96%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-3,798-4,609-8,498-10,771-8,467-7,347
Sale of Property, Plant & Equipment
1494492,2084341,3221,313
Cash Acquisitions
-3,340-4,008-267---
Divestitures
30,42630,4771,4588,60530,172-
Sale (Purchase) of Intangibles
-2,089-2,703-4,532-4,9597,840-6,147
Investment in Securities
5,2952,741106,84629,7273,821-6,433
Other Investing Activities
2692022,539-2,047-797
Investing Cash Flow
26,91222,54999,75433,03652,419-18,278

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
---84,00085,55929
Long-Term Debt Issued
--146,187---
Total Debt Issued
-1,100-146,18784,00085,55929
Short-Term Debt Repaid
--4,400-181,972---
Long-Term Debt Repaid
--86,540-73,614--20,060-4,960
Total Debt Repaid
-150,775-90,940-255,586--20,060-4,960
Net Debt Issued (Repaid)
-151,875-90,940-109,39984,00065,499-4,931
Common Dividends Paid
-2-2-3-2,792-11,125-11,126
Other Financing Activities
-331-324566-3,357-201,191-5,369
Financing Cash Flow
-55,333-91,266-108,83677,851-146,817-21,426

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
6,3845,024-17715,44024,09017,751
Miscellaneous Cash Flow Adjustments
13,760--13,1721,135-1,135-
Net Cash Flow
56,1878,022-5,931-114,431-59,5069,286

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
60,66667,1068,002-252,6643,47023,892
Free Cash Flow Growth
80.06%738.62%---85.48%-81.56%
Free Cash Flow Margin
12.78%14.80%2.01%-80.32%0.63%4.27%
Free Cash Flow Per Share
149.10168.9120.14-635.978.7360.14
Levered Free Cash Flow
80,33865,7075,270-253,96245,98815,575
Unlevered Free Cash Flow
80,33869,0608,132-251,52947,63817,431

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
4,3584,4914,3613,7342,4242,500
Cash Income Tax Paid
4,0904,564-12,18237,59525,45042,331
Change in Working Capital
-9,519-16,972-18,770-102,47041,509-6,607